Boundless Bio BOLD Cash Flow Statement (2023-2026)

NASDAQ BOLD
$2.43 +0.12 (+5.19%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

Boundless Bio Quarterly Cash Flow Statement

Periods 14 quarters
Latest Jun 2026

Boundless Bio reported cash from operations of -$20.95M and free cash flow of -$20.98M for the quarter ended Jun 2026, down 77.1% year over year. This cash flow statement covers 14 quarters of results from Mar 2023 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income -11.72M-12.40M-13.17M-12.14M-15.43M-16.98M-16.51M-16.45M-15.76M-15.68M-13.88M-12.89M-13.60M-23.69M
Depreciation and DepletionDep. & Depletion 0.24M0.24M0.26M0.27M0.80M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort. 0.20M0.20M0.21M0.25M0.26M0.30M0.26M0.30M0.32M0.32M0.31M0.31M0.28M1.26M
Share-based CompensationStock Comp. 0.62M0.93M0.88M0.91M1.33M2.14M2.05M2.01M1.80M1.69M1.30M1.33M1.37M3.22M
Other non-cash itemsOther Non-Cash 0.56M0.54M0.60M0.69M0.62M0.63M0.65M0.76M0.86M0.82M0.80M0.81M0.83M6.23M
Change in Working Capital
Change in Accured ExpensesChange Accured Exp. -0.90M1.16M0.86M0.55M-0.21M1.25M1.78M-2.05M-2.08M1.20M1.54M0.98M-3.07M1.47M
Change in Other Operating AssetsOther Assets Change 0.23M0.12M-0.35M-0.09M0.70M1.15M-0.55M-1.00M-0.21M0.42M0.03M-0.57M-0.25M-0.77M
Change in Other Operating LiabilitiesOther Liabilities Change -0.54M-0.54M-0.66M-0.82M-0.67M-0.69M-0.72M-0.08M0.94M0.94M0.33M-0.72M-0.75M-11.69M
Other Working Capital ChangesOther WC Changes -0.76M-0.66M-0.31M-0.73M-1.37M-1.83M-0.17M0.92M1.16M0.51M0.31M-0.15M-0.50M-10.92M
Cash from OperationsCash from Ops. -12.09M-10.89M-12.19M-11.69M-15.78M-16.24M-13.27M-15.56M-14.53M-11.83M-10.24M-10.10M-15.00M-20.95M
Investing Activities
Capital ExpendituresCapex 0.09M0.13M0.15M0.27M0.08M1.50M0.48M0.47M0.06M0.05M0.02M0.42M0.01M0.04M
Change in Property, Plant and EquipmentChange in PP&E -0.09M-0.13M-0.15M-0.27M-0.08M-1.50M-0.48M-0.47M-0.06M-0.05M-0.02M-0.42M-0.01M-0.04M
Purchase of InvestmentsInvestments Purchased 9.99M87.39M35.32M27.42M21.03M103.63M36.38M47.44M52.63M43.66M39.51M39.11M29.41M8.40M
Sale and Maturity of InvestmentsInvestments Sold 32.25M19.00M27.75M43.50M39.25M36.94M58.99M49.73M55.74M55.00M50.00M52.50M44.00M31.50M
Cash from Investing ActivitiesCash from Investing 22.17M-68.52M-7.72M15.81M18.14M-68.19M22.13M1.82M3.06M11.29M10.48M12.97M14.59M23.07M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued 0.03M0.03M0.09M0.04M0.06M93.00M0.11M0.02M
Net Shares Issued and RepurchasedNet Shares Issued 0.03M0.03M0.09M0.04M0.06M93.00M0.11M0.02M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued -0.33M
Net Equity Issued and RepurchasedNet Equity Issued 0.03M0.03M0.09M-0.29M0.06M93.00M0.11M0.02M
Other financing activitiesOther financing -0.33M-1.42M-0.98M-2.35M-0.01M
Cash from Financing ActivitiesCash from Financing 0.03M99.70M-0.45M-1.38M-0.92M90.65M-0.01M0.11M0.02M
Additional items
Change in Cash 10.11M20.29M-20.35M2.74M1.44M6.22M8.85M-13.63M-11.47M-0.42M0.28M2.89M-0.39M2.17M
Ending Cash Balance 21.59M41.88M21.52M24.27M25.70M31.92M40.77M27.15M15.68M15.26M15.54M18.43M18.04M20.21M
Free Cash FlowFCF -12.18M-11.02M-12.34M-11.95M-15.86M-17.74M-13.75M-16.03M-14.59M-11.88M-10.26M-10.52M-15.01M-20.98M
Net Cash FlowNCF 10.11M20.29M-20.35M2.74M1.44M6.22M8.85M-13.63M-11.47M-0.54M0.24M2.90M-0.41M2.13M

Boundless Bio Cash Flow Statement API

Pull Boundless Bio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=BOLD&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY